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Abstract: Lipocalin-2 (also known as NGAL) levels are elevated in obesity and diabetes yet relatively little is known 
regarding effects on the heart. We induced pressure overload (PO) in mice and found that lipocalin-2 knockout (LKO) 
mice exhibited less PO-induced autophagy and NLRP3 inflammasome activation than Wt. PO-induced mitochondrial 
damage was reduced and autophagic flux greater in LKO mice, which correlated with less cardiac dysfunction. All of 
these observations were negated upon adenoviral-mediated restoration of normal lipocalin-2 levels in LKO. Studies 
in primary cardiac fibroblasts indicated that lipocalin-2 enhanced priming and activation of NLRP3-inflammasome, 
detected by increased IL-1β, IL-18 and Caspase-1 activation. This was attenuated in cells isolated from NLRP3-
deficient mice or upon pharmacological inhibition of NLRP3. Furthermore, lipocalin-2 induced release of HMGB1 
from cells and NLRP3-inflammasome activation was attenuated by TLR4 inhibition. We also found evidence of 
increased inflammasome activation and reduced autophagy in cardiac biopsy samples from heart failure patients. 
Overall, this study provides new mechanistic insight on the detrimental role of lipocalin-2 in the development of 
cardiac dysfunction.
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Introduction
Heart failure (HF) incidence is increased in 
patients with obesity and diabetes and inflam-
mation is one underlying mechanism [1]. 
Lipocalin-2 (LCN2) is a proinflammatory adipo-
kine which is elevated in obesity and diabetes 
[2] and clinical studies have also established 
strong positive correlations between circulating 
LCN2 and various types of HF [3]. Thus, LCN2 
has been proposed as an important contributor 
to the pathophysiology of HF and potentially a 
useful biomarker for HF. Neutrophils are a 
major source of LCN2 which is also known 
as neutrophil gelatinase-associated lipocalin 
(NGAL) [4]. Mice lacking LCN2 were first shown 
to exhibit an increased susceptibility to bacteri-
al infections due to lack of antibacterial innate 
immune response [5] and subsequently shown 
to be protected from obesity- and aging-associ-
ated insulin resistance, endothelial dysfunction 
and hypertension [6-9]. However, the precise 
mechanisms via which LCN2 can regulate the 
progression of HF remain to be resolved.
In contrast to the paucity of information on car-
diac effects of LCN2, the pathophysiological 
role of LCN2/NGAL in kidney dysfunction is 
much better understood and measurement of 
LCN2/NGAL has recently become established 
as a common clinical diagnostic test for acute 
kidney damage [10]. Inflammation, including 
Lipocalin-2 regulates NLRP3 inflammasome
2724 Am J Transl Res 2017;9(6):2723-2735
NLRP3 (nucleotide-binding domain, leucine-
rich-containing family, pyrin domain-contain-
ing-3) inflammasome activation, and autopha-
gy have recently been established as important 
mechanisms regulating cardiac dysfunction 
[11, 12] although their regulation by LCN2 is 
unclear. We have recently shown that LCN2 
attenuates cardiomyocyte autophagy [13].
We hypothesized that LKO mice would have 
less pressure overload-induced cardiac dys-
function than wild type (WT) and that reduced 
autophagy or elevated NLRP3 inflammasome 
activation may be potential mechanisms of 
action. To examine this, we induced cardiac 
pressure overload (PO) in WT and LCN2 knock-
out mice (LKO) ± restoration of normal circulat-
ing LCN2 levels using adenovirus (L2AV). We 
first examined functional outcomes using echo-
cardiography, then analyzed mechanisms via 
which LCN2 contributed to cardiac dysfunction 
by focusing on fibrosis, autophagy and NLRP3 
inflammasome activation in these animal mod-
els as well as in primary cells isolated from 
heart of WT and NLRP3-deficient mice.
Material and methods 
Animals, induction of pressure overload and 
analysis of cardiac function
Male WT and LKO mice aged eight weeks with 
C57BL/6J background were studied using pro-
tocols approved by the Animal Care Committee 
at York University and the Committee on the 
Use of Live Animals for Teaching and Research 
of the University of Hong Kong and all methods 
were performed in accordance with these 
guidelines and regulations. Pressure overload 
was induced by transverse aortic banding as 
described previously [14]. Briefly, surgery was 
performed on the transverse aortae of mice 
under general anesthesia (ip; xylazine 0.15 
mg/g; ketamine 0.03 mg/g) with a titanium 
microligation clip using banding calipers cali-
brated to a 27-g needle. Sham surgery was per-
formed as outlined above without the place-
ment of a ligation clip. The recombinant adeno-
virus for LCN2 (108 plaque-forming units) was 
injected via tail vein of mice one day prior to 
surgery to achieve normal circulating levels [7] 
and echocardiography was performed using 
the Vevo2100 system (Visual Sonics) [15]. Sera 
were collected every week from tail vein and 
hearts were harvested at the ends points (four 
weeks). 
Cardiac biopsy from human subjects with or 
without heart failure (HF) 
Patients with end-stage dilated cardiomyopa-
thy (DCM) who met institutional criteria for 
LVAD device implantation as a bridge to trans-
plant or as destination therapy at the New York 
Presbyterian-Columbia Campus were included 
in this study and processed as previously 
described [14, 16]. Cardiac biopsy tissue used 
in this study (n=5) were all male, aged 
41.0±21.4 years and HF etiology ischemic or 
diabetic cardiomyopathy. All tissue obtained at 
LVAD implantation represented a decompen-
sated heart failure state. Normal patients were 
subjects with no known cardiopulmonary dis-
ease whose organs were listed but were unable 
to be placed at the time of organ recovery for 
heart transplantation and who consented to 
tissue for research purposes by the New York 
Organ Donor Network were included in this 
study. This study met all institutional guidelines 
of the Institutional Review Board of Columbia 
University and New York State organ donation 
guidelines regarding the use of clinical data, 
ethical treatment of patients adhering to the 
Declaration of Helsinki principles, and procure-
ment of tissue for research. All subjects were 
recruited at the New York Presbyterian Hospital-
Columbia University campus between 2008-
2014, and informed consent was waived for 
use of discarded, de-identified tissue.
Analysis of cardiac function using echocar-
diography
Echocardiography was performed using the 
Vevo2100 system (Visual Sonics, MS550D 
transducer) as previously described [15]. 
Cardiac systolic functions of ejection fraction, 
fractional shortening and strain rate calcula-
Table 1. Genes detected in fibrosis PCR array
Col1a1 Mmp8
Col3a1 Mmp9
Col4a1 Mmp13
Timp1 Mmp14
Timp2 Gapdh
Timp3 Actb
Mmp1a MGDC
Mmp2 PPC
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tion were based on M-mode images of the 
parasternal short-axis view at papillary level. All 
parameters were averaged over at least 3 car-
diac cycles for analysis.
Histological analysis of cardiac structure
Animals were sacrificed and hearts were iso-
lated and perfused with ice-cold cardioplegic 
solution (30 mM KCl in PBS) and stored in 10% 
neutral-buffered formalin 24 hours for further 
processing. Paraffin sections (5 μm) were pre-
pared for trichrome staining and immunostain-
ing using antibodies against HMGB1, desmin, 
vimentin or α-SMA as described previously [17]. 
Immunofluorescent analysis in cultured cells
Rat neonatal fibroblast cells were cultured in 
12-well plates, after treatment with or without 
murine recombinant LCN2 (1 μg/ml) protein for 
48 hours. Cells were fixed in 4% paraformalde-
hyde (PFA) for 15 minutes, quenched with 1% 
glycine for 10 minutes, and permeabilized with 
0.1% Triton X-100 for one minute. After blocking 
with 3% BSA, cells were incubated with murine 
LCN2 (1:200) and HMGB1 primary antibody 
(1:100) overnight at 4°C, and incubated with 
Alexa Fluor 488 goat anti-rabbit IgG (Life 
Technologies) at 1:1000 for one hour at room 
temperature. Images were taken using a 60 
objective with confocal microscope (Olympus, 
BX51).
Transmission electron microscopy (TEM)
TEM was performed as described previously 
[15]. In brief, LV myocardium was cut to 1 
mm3 and fixed with 2.5% glutaraldehyde in 
0.1 M cacodylate buffer (pH 7.4) overnight at 
4°C. After brief washing, the specimens were 
post-fixed in 1% osmium tetroxide, dehydrat-
ed, embedded in epoxy resin, and polymer-
ized overnight at 60°C. Ultra-thin sections 
(100 nm) were cut and post-stained with 
Reynold’s lead citrate and uranyl acetate to 
increase contrast. Sections were viewed and 
photographed using a P FEI CM100 TEM and 
Kodak Megaplus camera. 
Western blot analysis
Heart tissue was snap frozen and then lysed 
in modified RIPA buffer by the Tissue Lyser II 
(Qiagen) for two minutes at full speed. The 
lysates were then centrifuged at full speed for 
Table 2. Sequences of QPCR primers
Gene Name Primer Sequences
Murine Forward 5’CAGAACATCATCCCCTGCATC3’
Gapdh Reverse 5’CTGCTTCACCACCTTCTTGA3’
Murine Forward 5’GGTCACCCATGGCACCATAA3’
Nfκb1 Reverse 5’AGCTGCAGAGCCTTCTCAAG3’
Murine Forward 5’GCCACCTTTTGACAGTGATGAG3’
Il1β Reverse 5’AAGGTCCACGGGAAAGACAC3’
Murine Forward 5’GACACGAGTCCTGGTGACTT3’
Nlrp3 Reverse 5’GTCCACACAGAAAGTTCTCTTAGC3’
Murine Forward 5’AACGCCATGGCTGACAAGA3’
Casp1 Reverse 5’TGATCACATAGGTCCCGTGC3’
Murine Forward 5’CTG CGC TTG CAG AGA TTA AA3’
Tgfβ1 Reverse 5’GAA AGC CCT GTA TTC CGT CT3’
Rat Forward 5’ATGTGCCGGACCTTGGAAG3’
Gapdh Reverse 5’CCTCGGGTTAGCTGAGAGATCA3’
Rat Forward 5’CACTGCTCAGGTCCACTGTC3’
Nfkb1 Reverse 5’CTGTCACTATCCCGGAGTTCA3’
Rat Forward 5’CACCTCTCAAGCAGAGCACAG3’
Il1β Reverse 5’GGGTTCCATGGTGAAGTCAAC3’
Rat Forward 5’CCAGGGCTCTGTTCATTG3’
Nlrp3 Reverse 5’CCTTGGCTTTCACTTCG3’
Rat Forward 5’AGGAGGGAATATGTGGG3’
Casp1 Reverse 5’AACCTTGGGCTTGTCTT3’
10 minutes. Supernatants were harvested and 
quantified by BCA assay. Tissue lysates (30 or 
50 μg) were incubated with Laemmli sample 
buffer at 95°C for 10 minutes and then resolved 
by SDS-PAGE. After transferring to polyvinyli-
denedifluoride (PVDF) membranes, Western 
blotting was performed by incubating with anti-
bodies. The following antibodies were used for 
immunoblot analysis: LC3-II (1:1000), BECLIN-1 
(1:1000), Caspase-1 (1:1000), HMGB1 (1: 
1000), phospho-NF-κB p65 (Ser536) (1:750), 
NF-κB p65 (1:750), GAPDH (1:2000) and β-actin 
(1:2000) from Cell Signaling; p62 (1:1000) 
from BD Transduction Laboratories; LCN2 
(1:2000) from Antibody and Immunoassay 
Services; IL-1β (1:1000) from R&D systems. 
IL-18 (1:1000) from MBL Life science. After 
incubation with secondary antibodies, the imm- 
une complexes were detected with enhanced 
chemiluminescence (ECL) reagents from GE 
Healthcare (Uppsala, Sweden).
Quantitative reverse-transcription polymerase 
chain reaction
The custom fibrosis PCR array was purchased 
from SABiosciences-61 (QIAGEN Inc.). Total 
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RNA was isolated from heart tissues or cultured 
mice and rat fibroblasts using TRIzol® Reagent 
according to the manufacturer’s instructions, 
and purified using the RNeasyMinElute Cleanup 
Kit to attain an A260/A280 ratio between 1.9 
and 2.0. First-strand cDNA, synthesized from 
0.5 μg RNA using the RT2 First Strand kit, was 
used in a custom PCR array comprising of 
96-well plates pre-coated with primers listed in 
Table 1. Quantitative real-time PCR was con-
ducted using a Chromo4™ Detection system 
(Bio-Rad Laboratories Canada Ltd., Mississ- 
auga, ON, CA) according to cycling conditions 
outlined by the PCR array manufacturer. Data 
were analyzed using RT2 Profiler PCR Array Data 
Analysis software (Version 3.5; QIAGEN Inc.) 
and normalized to GAPDH mRNA expression. 
For other genes detected listed in the Table 2, 
they were analyzed through real-time PCR using 
the following cycling conditions: 95°C/15 min, 
followed by 35 cycles of [95°C/30 sec, 55°C/30 
sec, 72°C/30 sec], then 72°C/10 min. Melting 
curve analysis was used to ensure primer spec-
ificity. Data were then analyzed using the 2-ΔΔCt 
method.
Cultured adult fibroblasts from mice, adult and 
neonatal rat fibroblasts from rats
Mice (male, 8 weeks) or rat heart (Wistar rats 
male, 6 months) was isolated from anesthe-
tized animal and perfused with Ca2+ free 
K-H buffer for 6 minutes and then with 
LiberaseBlendyzme 4 (Roche) contained K-H 
Figure 1. Inflammasome activation is attenuated in LKO mice challenged with PO. (A) IL-1β levels were determined 
by ELISA in serum collected from WT and LKO mice subjected to either sham or PO surgery. (B) qPCR was per-
formed for gene expressions of inflammasome markers (Caspase-1, IL-1β, NLRP3 and NF-κB) in heart tissues col-
lected from WT and LKO mice subjected to either sham or PO surgery. (C, D) Western blotting and densitometric 
quantifications was performed to analyze HMGB1 protein levels in the heart tissues from the above treated mice. 
(E) Immunofluorescence was performed for HMGB1 in heart tissue sections collected from WT and LKO mice sub-
jected to either sham or PO surgery. Protein levels of LCN2 in heart tissue (F), densitometric quantification (F, left 
panel) and LCN2 level in circulation (F, right panel) were determined by Western blotting and ELISA, respectively. (G) 
Western blotting was performed to examine the protein levels of inflammation markers (LCN2, HMGB1, NF-κB and 
Caspase-1) in heart tissue lysates from healthy human subjects (Con) or patients with HF, with quantification shown 
in (H). *, P<0.05 vs. WT Sham or healthy human subjects and, #, vs. LKO PO, n=5-6.
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buffer for 3 times (10 ml per heart for mice, 20 
ml per heart for rat). The hearts were perfused 
with 5% BSA K-H buffer before mincing. After 
stabilization for 3 hours, fibroblasts were stimu-
lated with LCN2 (1 μg/ml) for 24 hours. Hearts 
were collected from 1- to 2-day-old neonatal rat 
pups, promptly after euthanasia by decapita-
tion, and primary cultures of neonatal rat car-
diomyocytes were performed as described pre-
viously [17]. After stabilization for 24 hours, 
neonatal rat fibroblasts were stimulated with 
LCN2 (1 μg/ml) for 48 hours. Samples were col-
lected to examine the expression levels of 
HMGB1 by western blot analysis and mRNA by 
quantitative RT-PCR. 
Statistical analysis
All results were derived from at least three sets 
of repeated experiments. The statistical calcu-
lations were performed by one-way analysis of 
variance followed by Tukey’s multiple compari-
Figure 2. LCN2 deficiency protects against loss of mitochondrial morphology and autophagy flux disruption induced 
by PO. A: Mitochondria integrity was evaluated using TEM from heart tissue sections of WT and LKO (±L2AV) mice 
that had undergone either sham or pressure overload (PO) surgery. Autophagosomes were indicated by arrows. 
B: Autophagic flux was analyzed by examining the protein expression of P62, LC3-II and BECLIN-1 in heart tissue 
lysates from WT and LKO (±L2AV) mice that have undergone either sham or PO surgery. C: Densitometric quantifica-
tions of western blots in B. D: Autophagic flux was analyzed by examining the protein expression of P62, LC3-II, and 
BECLIN-1 in heart tissue lysates from healthy human subjects (Con) or patients with heart failure (HF). E: Densito-
metric quantifications of western blots in D. *, P<0.05 vs. WT Sham or healthy human subjects and, #, vs. LKO PO, 
n=5-6.
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son post-test using Prism version 5 (Graph- 
PadSoftware; San Diego, CA, USA). Independent 
t tests were performed when there are compar-
isons between two groups. All values are pre-
sented as means ± SD and where arbitrary and 
not absolute value were involved the final graph 
displays fold over control values. For all statisti-
cal comparisons, a P value less than 0.05 was 
accepted to indicate significant differences.
Results
PO-induced inflammasome activation is at-
tenuated in LKO mice
We examined NLRP3 inflammasome in WT and 
LKO (±LCN2 restoration using L2AV) mice four 
weeks after transverse aortic banding surgery. 
Serum interleukin (IL)-1β measurement by 
ELISA demonstrated increased IL-1β in WT 
and LKO+L2AV with PO, although IL-1β was 
increased in LKO, the magnitude of change 
under PO was greatly reduced (Figure 1A). 
Inflammasome-priming, measured via expres-
sion levels of caspase-1, NLPR3, IL-1β and 
nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB) showed similar signifi-
cant increases in WT and LKO+L2AV after PO at 
the mRNA level (Figure 1B) [18]. Having shown 
that LCN2 positively regulates inflammasome 
activation in PO, we sought to decipher the 
mechanism of this action. NLRP3 inflamma-
some activation was previously shown to be 
regulated by the release of HMGB1 (high mobil-
ity group box chromosomal protein 1) from 
cells, after HMGB1-BECLIN-1 complex dissocia-
tion, via a mechanism involving toll-like recep-
tor (TLR)4-mediated signaling [19-21]. Both 
Western blotting of heart homogenates (Figure 
1C and 1D) and immunofluorescent detection 
in tissue sections (Figure 1E) demonstrated 
that HMGB1 was significantly decreased in WT 
but not LKO mice after PO. Under PO, restoring 
LCN2 in LKO mice with L2AV decreased cellular 
HMGB1 to amount similar as WT mice (Figure 
1E). After four weeks PO, a significant increase 
of LCN2 in both serum and heart tissue was 
detected in WT mice with PO (Figure 1F). In 
agreement with our mouse data, HMGB1 levels 
were significantly decreased in heart tissues of 
HF patients compared to healthy individuals 
(Figure 1G and 1H). Furthermore, cardiac con-
tent of LCN2, NF-κB and Caspase-1 were all sig-
nificantly increased in HF patients.
Figure 3. Development of PO-induced fibrosis is at-
tenuated in LKO mice. A: Masson’s trichrome staining 
of heart tissue taken from WT and LKO (±L2AV) mice 
four weeks following PO or sham surgery. Cardiomyo-
cytes are stained red, nuclei are stained black, and 
collagen is stained blue. B: Fibrosis PCR array was 
performed using heart tissues. Genes detected in this 
array are shown in Table 1. MMP-1, MMP-8, MMP-9 
are present. C: Fibroblast to myofibroblast differen-
tiation was assessed by co-staining with vimentin, 
α-SMA, and desmin in heart tissue sections from WT 
and LKO (±L2AV) mice that have undergone either 
sham surgery or PO. *, P<0.05 vs. WT Sham and, #, 
vs. LKO PO, n=4.
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LCN2 exacerbates mitochondrial deterioration 
and attenuates autophagic flux in response to 
PO 
Transmission electron microscopy indicated 
LCN2 deficiency greatly attenuated PO-induced 
mitochondria damage in cardiomyocytes, as 
shown by the presence of clear well-structured 
cristae in LKO mice before and after PO (Figure 
2A). This protective effect was partially lost 
with the administration of L2AV (Figure 2A). 
Transmission electron microscopy is a gold-
standard approach for analysis of autophagic 
structures, and our data indicated induction 
of autophagy in mice lacking LCN2 after 
PO-treatment (Figure 2A, arrow), with less 
observed in WT mice. Next, autophagic flux was 
evaluated by examining cardiac protein expres-
sion levels of P62, LC3-II, BECLIN-1. Western 
analysis showed increased protein expression 
of P62 and decreased LC3-II and BECLIN-1, 
suggesting less flux in WT versus LKO mice 
after PO (Figure 2B and 2C). Analysis of cardiac 
biopsy tissue samples obtained from human 
subjects with or without HF indicated increased 
P62 plus decreased LC3-II and BECLIN-1 levels 
(Figure 2D and 2E), indicative of less autopha-
gy when compared with control. It is conceiv-
able that signals such as reactive oxygen spe-
cies or mitochondria DNA released from dam-
aged mitochondria might be responsible for 
priming or activation of NLRP3 inflammasome 
[22, 23], whereas LCN-2 deficiency preserved 
mitochondria morphology and autophagic flux 
under PO.
LCN2 deficiency protects mice from PO-in-
duced development of fibrosis
Fibrosis is an established component of ven-
tricular remodeling in HF patients [14, 24]. Ma- 
sson’s trichrome staining revealed enhanced 
accumulation of collagen after PO in WT and 
LKO+L2AV, but not in LKO mice (Figure 3A). 
Assessing mRNA levels of fibrosis-related ge- 
nes showed matrix metalloproteinases (MMP)-
1, MMP-8 and TGF-β1 increased significantly 
after PO in WT and LKO+L2AV mice but not in 
LKO mice (Figure 3B). MMP-9 levels increased 
after restoring LCN2 in LKO with L2AV under 
both sham, and to a greater extent, PO condi-
tions (Figure 3B). Immunofluorescence staining 
showed that LKO mice were somewhat protect-
ed against PO-induced occurrence of vimentin-
positive fibroblasts (Figure 3C). Administration 
of L2AV to LKO mice negated these protective 
Figure 4. Temporal analysis of car-
diac dysfunction using echocardiog-
raphy after thoracic aorta banding 
or sham surgery. A: Ejection Fraction 
(EF); B: Fractional Shortening (FS); C: 
Circumferential systole strain rate; D: 
Circumferential diastole strain rate; 
E: Circumferential strain change 
percentage. *, P<0.05 vs. WT Sham 
and, #, vs. LKO PO, n=5-7. L2AV, li-
pocalin-2 adenovirus. LKO PO, lipo-
calin-2 knock-out mice with pressure 
overload surgery.
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effects; however, there was much less accumu-
lation of fibroblasts compared to WT mice with 
PO (Figure 3C). Immunostaining for smooth 
muscle actin (SMA) showed that there was no 
interstitial activation of myofibroblast after PO 
in all six groups, as expected from this model of 
mild PO (Figure 3C).
LCN2 deficiency protects mice from PO-in-
duced development of cardiac dysfunction
Cardiac function of WT and LKO (±LCN2 resto-
ration using L2AV) mice was evaluated by echo-
cardiography four weeks after transverse aortic 
banding surgery. Consistent with previous 
reports [9], LKO mice demonstrated a higher 
ejection fraction (EF) and fractional shortening 
(FS) compared to age-matched WT mice that 
showed significant PO-induced cardiac dys-
function (Figure 4A and 4B). This heart protec-
tive effect in LKO mice was abolished by admin-
istration of LCN2 (Figure 4A and 4B) as the 
basal level of EF and ES in LKO mice treated 
with L2AV was similar to WT mice (Figure 4A 
and 4B). Importantly, we validated the effec-
tiveness of adenoviral LCN2 delivery by show- 
ing that circulating LCN2 produced by L2AV 
reached a peak above normal level observed 
in WT mice one week after virus injection 
(Supplementary Figure 1) [7]. An inherent limi-
tation of this approach is that levels gradually 
decline after 2 and 4 weeks yet we did not per-
form a second adenovirus injection to avoid 
confounding effects from immune system acti-
vation and inflammation. As visualized in repre-
sentative short axis images of M-mode and 
speckle tracking echocardiography (Supple- 
mentary Figure 2), ventricular wall constriction 
and both systole (Figure 4C) and diastole 
(Figure 4D) circumferential strain rate in WT 
and LKO+L2AV mice under PO dropped signifi-
cantly four weeks after PO, but were preserved 
in LKO mice (Figure 4E; Supplementary Table 
1). PO induced increased LV mass and the 
response was similar in both genotypes and in 
LKO with LCN2 replenishment (Supplementary 
Figure 5. LCN2 treatment of rat neo-fibroblasts interrupts autophagic flux and induces inflammasome activation by 
releasing HMGB1. Rat neo-fibroblasts were isolated and treated with recombinant LCN2 (1 μg/ml) or control for 48 
hours. Immunofluorescence (A) and Western blotting (B) were performed to examine the localization and protein 
expression levels of HMGB1 fibroblasts and IL-18 and IL-1β in medium. Expression levels of inflammasome markers 
showed in the graph (C) were examined by qPCR. (D) Western blotting was performed to examine the protein levels 
of autophagic markers (LCN2, LC3-II, P62 and BECLIN-1) with quantification shown in (E). (F, G) Co-immunoprecipita-
tion (Co-IP) was performed in neonatal fibroblast cells to evaluate the binding status between BECLIN-1 and HMGB1. 
*, P<0.05, **, P<0.01 vs. corresponding control, n=3.
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Figure 3). In summary, these data indicate a 
detrimental role of LCN2 in the development of 
cardiac dysfunction.
LCN2 acts directly on primary cardiac fibro-
blasts to decrease intracellular HMGB1 levels, 
induce NLRP3 inflammasome activation and 
attenuate autophagy
During pathological conditions, cardiac fibro-
blasts play a crucial role in maintaining normal 
cardiac function by modulating the synthesis 
not only via deposition of extracellular matrix, 
but also upon autocrine and paracrine cell-to-
cell communication [25]. We observed accumu-
lation of fibroblasts after PO model and these 
may play a role in NLRP3 inflammasome com-
plex formation. To test this possibility, we iso-
lated primary cardiac fibroblasts from neonatal 
rats and treated with recombinant LCN2 for 48 
hours. Immunofluorescent staining indicated 
increased LCN2 signal in the cytosol and 
reduced cytosolic HMGB1 levels in cells treated 
with LCN2 (Figure 5A). Western blotting data 
also confirmed that total cellular HMGB1 levels 
were decreased after LCN2 treatment (Figure 
5B, lower). Meanwhile, HMGB1 was detected in 
concentrated conditioned medium after LCN2 
treatment (Figure 5B, top). Protein levels of 
IL-1β and IL-18 were also increased in this 
medium after LCN2 treatment (Figure 5B, top). 
Gene expressions of Caspase-1, IL-1β, NLRP3 
and NF-κB in fibroblasts (Figure 5C) were 
induced by LCN2 treatment. We found that 
LCN2 also had direct effects on protein mark-
ers of autophagy with decreased LC3-II and 
elevated P62 levels and a reduction in BECLIN-1 
(Figure 5D and 5E). HMGB1 also regulates 
autophagy by competing for BECLIN-1 binding 
with Bcl-2. To determine whether the interrup-
tion of autophagy is due to decreased binding 
between HMGB1 and BECLIN-1 after LCN2 tre- 
atment of cells, we immunoprecipitated BEC- 
LIN-1 and observed less association of HMGB1 
after LCN2 treatment (Figure 5F and 5G).
LCN2 induced inflammasome activation is 
attenuated by NLRP3 deficiency and TLR4 
inhibition
Primary cardiac fibroblasts from WT and NLRP3 
knockout (NLRP3-/-) adult mice were treated 
in culture with recombinant LCN2 or NLRP3 
inflammasome activator lipopolysaccharide/
adenosine triphosphate (LPS/ATP) for 24 h 
[26]. LCN2 treatment increased mRNA levels of 
inflammasome related genes Caspase-1 and 
IL-1β in WT mice but not in NLPR3-/- mice 
Figure 6. LCN2 induced inflammasome activation is attenuated by NLRP3 deficiency. Wild type and NLRP3-/- mice 
heart fibroblasts were isolated and treated with recombinant LCN2 (1 μg/ml) or ATP plus LPS for 24 hours. Expres-
sion levels of inflammasome markers, Caspase-1 (A), IL-1β (B), NF-κB (C) and NLRP3 (D) were examined by qPCR. 
Adult rat heart fibroblasts were isolated and treated with recombinant LCN2 (1 μg/ml) or ATP (5 μM) plus LPS (2.5 
μg/ml) for 24 hours in the presence or absence of NLRP3 inhibitor MCC-950 (0.1 μM). (E) Western blotting was per-
formed to examine the protein levels of LCN2 and inflammatory markers in medium (IL-1β) and fibroblasts (HMGB1, 
Caspase-1, pNF-κB, tNF-κB). Caspase-1 (F) and IL-1β (G) mRNA levels were checked by qPCR. *, P<0.05, **, P<0.01 
vs. corresponding control, n=3.
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(Figure 6A-D). When treat-
ed with LCN2 and LPS/ATP 
in the presence or absence 
of NLRP3 inhibitor (MCC-
950) or TLR4 inhibitor (Cli-
095), mRNA levels of Ca- 
spase-1 and IL-1β were sig-
nificantly attenuated (Fig- 
ures 6F, 6G, 7B and 7C). 
Figure 7. LCN2 induced inflammasome activation is attenuated by TLR4 inhibition. Adult rat heart fibroblasts were 
isolated and treated with recombinant LCN2 (1 μg/ml) or ATP (5 μM) plus LPS (2.5 μg/ml) for 24 hours in the pres-
ence or absence of TLR4 inhibitor Cli-095 (1 μg/ml). (A) Western blotting was performed to examine the protein 
levels of LCN2 and inflammatory markers in medium (IL-1β) and fibroblasts (HMGB1, Caspase-1, pNF-κB, tNF-κB). 
Caspase-1 (B) and IL-1β (C) mRNA levels were checked by qPCR. *, P<0.05, **, P<0.01 vs. corresponding control, 
n=3.
Figure 8. Schematic model depicting mechanisms via which LCN2 regulates 
NLRP3 inflammasome. LCN2 disrupts the association of BECLIN-1 and HMGB1, 
one consequence of which is altered autophagic flux (left side). Another is 
HMGB1 release from cells which can then induce an inflammatory response 
by binding to TLR4 receptors (right side). LCN2 also induced mitochondrial 
dysfunction and we propose that consequent increases in ROS or mtDNA may 
contribute to priming and activation of the NLRP3 inflammasome. The end re-
sult of NLRP3 inflammasome activation is production and cleavage of proin-
flammatory cytokines (IL-1 β 
and IL-18) via Caspase-1 acti-
vation. Together these effects 
may dictate cardiac remodel-
ing events such as fibrosis. 
ASC, apoptosis-associated sp- 
eck-like protein; Bcl-2, B-cell 
lymphoma 2; CARD, caspase 
activation and recruitment 
domain. IL-1β, interleukin-1β; 
IL-18, interleukin-18; NF-κB, 
transcription factor nuclear 
factor kappa-light chain-en-
hancer of activated B cells; 
NLRP3, NACHT, LRR and PYD 
domains-containing protein 3; 
TLR-4, toll-like receptor 4.
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MCC-950 and Cli-095 also attenuated the level 
of LCN2 induced IL-1β release into the media, 
as well as Caspase-1 and phospho-NF-κB p65 
(Ser536) content in rat adult fibroblasts 
(Figures 6E and 7A). Consistently, the protein 
expression level of HMGB1 decreased after 
LCN2 treatment, but not LPS/ATP treatment, 
indicating the role of LCN2 in releasing HMGB1 
from the cytosol (Figures 6E and 7A). 
Discussion
Our analysis of the contribution by LCN2 to car-
diac dysfunction, and in particular the discov-
ery of novel mechanisms of LCN2 action has 
wide-ranging diagnostic and therapeutic impli-
cations, not only in heart failure but also other 
conditions such as kidney dysfunction. A princi-
pal novel discovery of this study was that LCN2 
induced NLRP3 inflammasome activation via 
release of the danger-associated molecular 
pattern (DAMP) protein HMGB1 and subse-
quent TLR4-dependent signaling. Our results 
revealed that lack of LCN2 in mice mitigates 
maladaptive fibrotic remodeling and facilitates 
adequate induction of autophagic flux in 
response to PO, in keeping with our previous 
work indicating that LCN2 directly attenuated 
autophagic flux [13]. Thus, we have validated 
the functional consequences of cardiac LCN2 
actions and provided new insight into the 
mechanisms involved (Figure 8).
An important impact of NLRP3 inflammasome 
activation in diabetes and cardiovascular dis-
ease is well documented [11, 27, 28]. Previous 
studies showed that serum LCN2 levels corre-
late positively with various cardiovascular dis-
eases including HF [2]. Basal expression of 
LCN2 in heart tissue is low and we found that 
direct administration of LCN2 accelerated the 
progression of HF [6]. One of the best charac-
terized DAMPs is HMGB1 which promotes 
NLRP3 inflammasome and NF-κB activation 
[29]. Effects of HMGB1 can be mediated via 
several mechanisms, including HMGB1 binding 
to receptor for advanced glycation end prod-
ucts (RAGE) and toll-like receptors TLR2 and 
TLR4 [21, 29]. In astrocytes, the inhibition of 
TLR4, rather than RAGE or TLR2 attenuated 
HMGB1-induced IL-18 production [30]. We 
found decreased intracellular HMGB1 levels in 
rat adult and neonatal fibroblasts treated with 
LCN2, suggesting that LCN2 induces release 
of HMGB1 into the extracellular space by an 
as yet unknown mechanism. Furthermore, we 
found decreased HMGB1 levels in WT and 
LKO+L2AV, but not LKO mice after PO as well 
as in cardiac biopsy samples of human HF 
patients. Our data indicated that NLRP3 inflam-
masome was initiated by LCN2 via the release 
of HMGB1 followed by TLR-4 activation and 
mitochondria damage, thus assembling various 
lines of evidence in the literature into a detailed 
cohesive mechanism of LCN2 action. The 
induction of the NLRP3 inflammasome complex 
and subsequent inflammatory effects are then 
reasonably considered to contribute to cardiac 
dysfunction.
Reciprocal crosstalk between NLRP3 inflam-
masome activation and LCN2 action was sug-
gested by studies showing that stimulation of 
TLR4 induces the formation of the inflamma-
some complex and production of LCN2 [31]. 
Many studies have now indicated that the 
degree of autophagy changes in the failing 
heart although the functional significance is 
still contentious [32]. Disruption of autophagy 
by cardiac-specific knockdown of Atg5 in mice 
leads to cardiomyopathy [33]. We believe that 
LCN2 is an important suppressor of cardiac 
autophagy and have recently shown reduced 
autophagic flux in cardiomyoblast cells treated 
with LCN2 [13]. Our current study provides evi-
dence that the increase in cardiac autophagy 
normally seen in response to PO, and which is 
generally regarded as a beneficial adaptive 
response, is enhanced in LKO mice and attenu-
ated by adenoviral delivery of LCN2 to these 
mice. Together, these data indicate that LCN2 
acts to suppress cardiac autophagic flux and 
this likely contributes to cardiac dysfunction. 
Interestingly, sustained autophagy upon trans-
genic Atg7 overexpression in mice decreased 
cardiac fibrosis and dysfunction [34]. We 
showed that LKO mice were somewhat protect-
ed against PO-induced induction of vimentin-
positive fibroblasts and fibrosis, while adminis-
tration of L2AV to LKO mice negated these pro-
tective effects. In addition to the classic role of 
extracellular matrix regulation, MMP-9 activity 
can also contribute to inflammation in the fail-
ing heart via activation of inflammatory cyto-
kines such as IL-1β, IL-8 and tumor necrosis 
factor alpha (TNF-α) [35].
In conclusion, our study confirms the detrimen-
tal role of LCN2 in development of cardiac dys-
function and provides new mechanistic insight 
on mechanisms of LCN2 action. Indeed, the 
effects which we have observed in this study 
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could well be at least in part mediated via sys-
temic effects of LCN2 in other tissues which 
causes crosstalk with the heart. A principal 
novel discovery of this study was that LCN2 
induced NLRP3 inflammasome activation via 
release of the danger-associated molecular 
pattern (DAMP) protein HMGB1 and subse-
quent TLR4-dependent signaling. This study 
also provided further evidence that LCN2 acts 
to suppress stress-induced autophagic flux. 
Our focus was on the heart yet this data has 
potentially wide-ranging diagnostic and thera-
peutic implications, since the physiological sig-
nificance of LCN2, also commonly referred to 
as NGAL, is perhaps most well established in 
kidney. Nevertheless, potential for suppressing 
neutrophil-derived LCN2-mediated inflamma-
tion must be balances by potential adverse 
effects of over-suppression due to the benefi-
cial role of neutrophils in cardiac repair by 
polarizing macrophages towards a reparative 
phenotype [36]. This work will also likely stimu-
late interest in new avenues of research on the 
regulation of NLRP3 inflammasome, autophagy 
and fibrosis by LCN2 in other target tissues. In 
summary, we have characterized the cardiac 
functional consequences of LCN2 deletion, 
with or without readministration, in mice and 
provided new insight into the mechanisms 
involved.
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Supplementary Figure 1. Sera were collected in both 8- and 12-weeks-old WT mice and LKO mice with L2AV restora-
tion for 1, 2 and 4 weeks. Sera LCN2 were evaluated by Elisa. n=3-5.
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Supplementary Figure 2. Representative M-mode images of short-axis view of LV and representative images of 
circumferential strain rate during 5 cardiac cycles. 
Supplementary Table 1. Analysis of cardiac parameters of mice heart four weeks after thoracic aorta 
banding surgery
WT SHAM WT PO LKO SHAM LKO PO LKO+L2AV SHAM LKO+L2AV PO
Cardiac output (ml/min) 21.12±3.16 21.14±4.24 21.98±3.97 22.26±6.79 20.83±3.14 17.35±3.20*
LVEDD (mm) 3.21±0.31 3.71±0.39* 3.23±0.32 3.66±0.32 3.51±0.29 3.87±0.31*
LVESD (mm) 1.86±0.25 2.42±0.29* 1.70±0.26 2.22±0.35 2.04±0.24 2.68±0.27*
LVEDV (μl) 42.23±9.77 59.25±14.35* 42.63±10.28 57.34±11.03* 51.96±10.98 65.72±12.56*
LVESV (μl) 11.22±3.75 23.15±4.83* 8.78±3.42 17.36±6.71* 13.88±4.20 27.90±11.56*,#
LV mass (mg) 89.03±17.01 117.85±6.72* 94.05±32.04 121.99±4.62* 88.99±18.50 114.02±8.77*
StrokeVolume (μl) 31.00±6.57 38.57±8.45* 33.85±6.86 39.96±7.51* 38.07±6.94* 37.80±3.10*
Left ventricular end-systolic diameter (LVESD); Left ventricular end-diastolic diameter (LVEDD); Left ventricular end-systolic volume (LVESV); Left 
ventricular end-systolic volume (LVEDV). *, P<0.05 vs. corresponding WT shamand, #, vs. LKO PO, n=5-7.
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Supplementary Figure 3. Protein level of ANP (A, 
B) and gene expression level of ANP, BNP (C) were 
checked from heart tissues collected from each 
group. (D, E) WGA staining were performed to 
checked the cardiomyocytes remodeling in heart tis-
sue sections collected from WT and LKO mice chal-
lenged with pressure overload. *, P<0.05 vs. corre-
sponding WT sham, n=4.
